Research Article
Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
Table 2
Relationship between anti-AQP4 Ab serum concentrations, complement-mediated cytotoxicity, and clinical parameters.
| ||||||||||||||||||||||||||||||||||||
Anti-AQP4 Ab serum concentration and complement-mediated serum cytotoxicity were measured in 30 sera from 10 NMO patients with a cell-based assay as described in methods. We compared both biological parameters in samples taken in relapsing phase (<1 month after a relapse) versus remitting phase and in the 5 more disabled patients (i.e., with the highest EDSS scores) versus the other ones. P: alpha risk. |